Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $74.9 million.

  • Prestige Consumer Healthcare's Operating Expenses rose 838.22% to $74.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $296.9 million, marking a year-over-year increase of 391.01%. This contributed to the annual value of $297.7 million for FY2025, which is 555.6% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Operating Expenses stood at $74.9 million for Q4 2025, which was up 838.22% from $71.9 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Operating Expenses high stood at $434.8 million for Q1 2023, and its period low was $63.2 million during Q4 2022.
  • Its 5-year average for Operating Expenses is $90.0 million, with a median of $71.8 million in 2023.
  • In the last 5 years, Prestige Consumer Healthcare's Operating Expenses soared by 50859.36% in 2023 and then crashed by 8397.65% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Operating Expenses (Quarter) stood at $72.5 million in 2021, then fell by 12.76% to $63.2 million in 2022, then increased by 12.48% to $71.1 million in 2023, then dropped by 2.84% to $69.1 million in 2024, then grew by 8.38% to $74.9 million in 2025.
  • Its Operating Expenses stands at $74.9 million for Q4 2025, versus $71.9 million for Q3 2025 and $68.6 million for Q2 2025.